Endonucleases Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Eukaryotic Enzymes, Prokaryotic Enzymes); Application (Polymerase Chain Reaction (PCR), Restriction Fragment Length Polymorphism (RFLP), Epigenetics, Restriction Digestion, Sequencing, Cloning); End User (Pharmaceutical and Biotechnology Companies, Research Organizations, Medical Institutes), and Geography
Report Code: TIPRE00020931 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Endonucleases are enzymes or proteins that slice the phosphodiester bond inside a polynucleotide chain. For instance, deoxyribonuclease I, cut DNA comparatively nonspecifically. Various endonucleases act as restriction endonucleases or restriction enzymes that enable cuts only at very specific nucleotide sequences.
MARKET DYNAMICS
The endonucleases market growth is estimated to grow due to the increasing research and development, growing demand from academic institutes, and rising production of biopharmaceutical products. In addition, the growing applications of genomic, and proteomic are likely to serve growth opportunities for the market during the forecast period.
MARKET SCOPE
The "Endonucleases Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of endonucleases market with detailed market segmentation by type, application, and end user. The endonucleases market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in endonucleases market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The endonucleases market is segmented on the basis of type, application, and end user. Based on type, the market is classified as eukaryotic enzymes, and prokaryotic enzymes. Based on application, the market is classified as polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP), epigenetics, restriction digestion, sequencing, and cloning. And on the basis of application, the market is segmented as pharmaceutical and biotechnology companies, research organizations, and medical institutes.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the endonucleases market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SCAM). The endonucleases market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting endonucleases market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the endonucleases market in these regions.
The report covers key developments in the endonucleases market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from endonucleases market are anticipated to have lucrative growth opportunities in the future with the rising demand for endonucleases market in the global market. Below mentioned is the list of few companies engaged in the endonucleases market.
The report also includes the profiles of key players in endonucleases market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Endonucleases are enzymes or proteins that slice the phosphodiester bond inside a polynucleotide chain. For instance, deoxyribonuclease I, cut DNA comparatively nonspecifically. Various endonucleases act as restriction endonucleases or restriction enzymes that enable cuts only at very specific nucleotide sequences.
MARKET DYNAMICS
The endonucleases market growth is estimated to grow due to the increasing research and development, growing demand from academic institutes, and rising production of biopharmaceutical products. In addition, the growing applications of genomic, and proteomic are likely to serve growth opportunities for the market during the forecast period.
MARKET SCOPE
The "Endonucleases Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of endonucleases market with detailed market segmentation by type, application, and end user. The endonucleases market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in endonucleases market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The endonucleases market is segmented on the basis of type, application, and end user. Based on type, the market is classified as eukaryotic enzymes, and prokaryotic enzymes. Based on application, the market is classified as polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP), epigenetics, restriction digestion, sequencing, and cloning. And on the basis of application, the market is segmented as pharmaceutical and biotechnology companies, research organizations, and medical institutes.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the endonucleases market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SCAM). The endonucleases market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting endonucleases market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the endonucleases market in these regions.
The report covers key developments in the endonucleases market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from endonucleases market are anticipated to have lucrative growth opportunities in the future with the rising demand for endonucleases market in the global market. Below mentioned is the list of few companies engaged in the endonucleases market.
The report also includes the profiles of key players in endonucleases market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Merck KGaA
- New England Biolabs, Inc.
- Promega Corporation
- Genetics Biotech Asia Pvt. Ltd
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- PerkinElmer, Inc
- bluebird bio, Inc.
- BioVision, Inc.
- Integrated DNA Technologies, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Endonucleases Market - By Type
1.3.2 Endonucleases Market - By Application
1.3.3 Endonucleases Market - By End User
1.3.4 Endonucleases Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ENDONUCLEASES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ENDONUCLEASES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ENDONUCLEASES MARKET - GLOBAL MARKET ANALYSIS
6.1. ENDONUCLEASES - GLOBAL MARKET OVERVIEW
6.2. ENDONUCLEASES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ENDONUCLEASES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. EUKARYOTIC ENZYMES
7.3.1. Overview
7.3.2. Eukaryotic Enzymes Market Forecast and Analysis
7.3.3. Neurospora Endonuclease Market
7.3.3.1. Overview
7.3.3.2. Neurospora Endonuclease Market Forecast and Analysis
7.3.4. P1 Endonuclease Market
7.3.4.1. Overview
7.3.4.2. P1 Endonuclease Market Forecast and Analysis
7.3.5. S1 Endonuclease Market
7.3.5.1. Overview
7.3.5.2. S1 Endonuclease Market Forecast and Analysis
7.3.6. Mung Bean Endonuclease I Market
7.3.6.1. Overview
7.3.6.2. Mung Bean Endonuclease I Market Forecast and Analysis
7.3.7. Dnase I Market
7.3.7.1. Overview
7.3.7.2. Dnase I Market Forecast and Analysis
7.3.8. Others Market
7.3.8.1. Overview
7.3.8.2. Others Market Forecast and Analysis
7.4. PROKARYOTIC ENZYMES
7.4.1. Overview
7.4.2. Prokaryotic Enzymes Market Forecast and Analysis
7.4.3. Bal 31 Endonuclease Market
7.4.3.1. Overview
7.4.3.2. Bal 31 Endonuclease Market Forecast and Analysis
7.4.4. T7 Endonuclease Market
7.4.4.1. Overview
7.4.4.2. T7 Endonuclease Market Forecast and Analysis
7.4.5. RecBCD Endonuclease Market
7.4.5.1. Overview
7.4.5.2. RecBCD Endonuclease Market Forecast and Analysis
7.4.6. T4 Endonuclease II Market
7.4.6.1. Overview
7.4.6.2. T4 Endonuclease II Market Forecast and Analysis
7.4.7. Others Market
7.4.7.1. Overview
7.4.7.2. Others Market Forecast and Analysis
8. ENDONUCLEASES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. POLYMERASE CHAIN REACTION (PCR)
8.3.1. Overview
8.3.2. Polymerase Chain Reaction (PCR) Market Forecast and Analysis
8.4. RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP)
8.4.1. Overview
8.4.2. Restriction Fragment Length Polymorphism (RFLP) Market Forecast and Analysis
8.5. EPIGENETICS
8.5.1. Overview
8.5.2. Epigenetics Market Forecast and Analysis
8.6. RESTRICTION DIGESTION
8.6.1. Overview
8.6.2. Restriction Digestion Market Forecast and Analysis
8.7. SEQUENCING
8.7.1. Overview
8.7.2. Sequencing Market Forecast and Analysis
8.8. CLONING
8.8.1. Overview
8.8.2. Cloning Market Forecast and Analysis
9. ENDONUCLEASES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.3.1. Overview
9.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
9.4. RESEARCH ORGANIZATIONS
9.4.1. Overview
9.4.2. Research Organizations Market Forecast and Analysis
9.5. MEDICAL INSTITUTES
9.5.1. Overview
9.5.2. Medical Institutes Market Forecast and Analysis
10. ENDONUCLEASES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Endonucleases Market Overview
10.1.2 North America Endonucleases Market Forecasts and Analysis
10.1.3 North America Endonucleases Market Forecasts and Analysis - By Type
10.1.4 North America Endonucleases Market Forecasts and Analysis - By Application
10.1.5 North America Endonucleases Market Forecasts and Analysis - By End User
10.1.6 North America Endonucleases Market Forecasts and Analysis - By Countries
10.1.6.1 United States Endonucleases Market
10.1.6.1.1 United States Endonucleases Market by Type
10.1.6.1.2 United States Endonucleases Market by Application
10.1.6.1.3 United States Endonucleases Market by End User
10.1.6.2 Canada Endonucleases Market
10.1.6.2.1 Canada Endonucleases Market by Type
10.1.6.2.2 Canada Endonucleases Market by Application
10.1.6.2.3 Canada Endonucleases Market by End User
10.1.6.3 Mexico Endonucleases Market
10.1.6.3.1 Mexico Endonucleases Market by Type
10.1.6.3.2 Mexico Endonucleases Market by Application
10.1.6.3.3 Mexico Endonucleases Market by End User
10.2. EUROPE
10.2.1 Europe Endonucleases Market Overview
10.2.2 Europe Endonucleases Market Forecasts and Analysis
10.2.3 Europe Endonucleases Market Forecasts and Analysis - By Type
10.2.4 Europe Endonucleases Market Forecasts and Analysis - By Application
10.2.5 Europe Endonucleases Market Forecasts and Analysis - By End User
10.2.6 Europe Endonucleases Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Endonucleases Market
10.2.6.1.1 Germany Endonucleases Market by Type
10.2.6.1.2 Germany Endonucleases Market by Application
10.2.6.1.3 Germany Endonucleases Market by End User
10.2.6.2 France Endonucleases Market
10.2.6.2.1 France Endonucleases Market by Type
10.2.6.2.2 France Endonucleases Market by Application
10.2.6.2.3 France Endonucleases Market by End User
10.2.6.3 Italy Endonucleases Market
10.2.6.3.1 Italy Endonucleases Market by Type
10.2.6.3.2 Italy Endonucleases Market by Application
10.2.6.3.3 Italy Endonucleases Market by End User
10.2.6.4 Spain Endonucleases Market
10.2.6.4.1 Spain Endonucleases Market by Type
10.2.6.4.2 Spain Endonucleases Market by Application
10.2.6.4.3 Spain Endonucleases Market by End User
10.2.6.5 United Kingdom Endonucleases Market
10.2.6.5.1 United Kingdom Endonucleases Market by Type
10.2.6.5.2 United Kingdom Endonucleases Market by Application
10.2.6.5.3 United Kingdom Endonucleases Market by End User
10.2.6.6 Rest of Europe Endonucleases Market
10.2.6.6.1 Rest of Europe Endonucleases Market by Type
10.2.6.6.2 Rest of Europe Endonucleases Market by Application
10.2.6.6.3 Rest of Europe Endonucleases Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Endonucleases Market Overview
10.3.2 Asia-Pacific Endonucleases Market Forecasts and Analysis
10.3.3 Asia-Pacific Endonucleases Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Endonucleases Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Endonucleases Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Endonucleases Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Endonucleases Market
10.3.6.1.1 Australia Endonucleases Market by Type
10.3.6.1.2 Australia Endonucleases Market by Application
10.3.6.1.3 Australia Endonucleases Market by End User
10.3.6.2 China Endonucleases Market
10.3.6.2.1 China Endonucleases Market by Type
10.3.6.2.2 China Endonucleases Market by Application
10.3.6.2.3 China Endonucleases Market by End User
10.3.6.3 India Endonucleases Market
10.3.6.3.1 India Endonucleases Market by Type
10.3.6.3.2 India Endonucleases Market by Application
10.3.6.3.3 India Endonucleases Market by End User
10.3.6.4 Japan Endonucleases Market
10.3.6.4.1 Japan Endonucleases Market by Type
10.3.6.4.2 Japan Endonucleases Market by Application
10.3.6.4.3 Japan Endonucleases Market by End User
10.3.6.5 South Korea Endonucleases Market
10.3.6.5.1 South Korea Endonucleases Market by Type
10.3.6.5.2 South Korea Endonucleases Market by Application
10.3.6.5.3 South Korea Endonucleases Market by End User
10.3.6.6 Rest of Asia-Pacific Endonucleases Market
10.3.6.6.1 Rest of Asia-Pacific Endonucleases Market by Type
10.3.6.6.2 Rest of Asia-Pacific Endonucleases Market by Application
10.3.6.6.3 Rest of Asia-Pacific Endonucleases Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Endonucleases Market Overview
10.4.2 Middle East and Africa Endonucleases Market Forecasts and Analysis
10.4.3 Middle East and Africa Endonucleases Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Endonucleases Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Endonucleases Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Endonucleases Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Endonucleases Market
10.4.6.1.1 South Africa Endonucleases Market by Type
10.4.6.1.2 South Africa Endonucleases Market by Application
10.4.6.1.3 South Africa Endonucleases Market by End User
10.4.6.2 Saudi Arabia Endonucleases Market
10.4.6.2.1 Saudi Arabia Endonucleases Market by Type
10.4.6.2.2 Saudi Arabia Endonucleases Market by Application
10.4.6.2.3 Saudi Arabia Endonucleases Market by End User
10.4.6.3 U.A.E Endonucleases Market
10.4.6.3.1 U.A.E Endonucleases Market by Type
10.4.6.3.2 U.A.E Endonucleases Market by Application
10.4.6.3.3 U.A.E Endonucleases Market by End User
10.4.6.4 Rest of Middle East and Africa Endonucleases Market
10.4.6.4.1 Rest of Middle East and Africa Endonucleases Market by Type
10.4.6.4.2 Rest of Middle East and Africa Endonucleases Market by Application
10.4.6.4.3 Rest of Middle East and Africa Endonucleases Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Endonucleases Market Overview
10.5.2 South and Central America Endonucleases Market Forecasts and Analysis
10.5.3 South and Central America Endonucleases Market Forecasts and Analysis - By Type
10.5.4 South and Central America Endonucleases Market Forecasts and Analysis - By Application
10.5.5 South and Central America Endonucleases Market Forecasts and Analysis - By End User
10.5.6 South and Central America Endonucleases Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Endonucleases Market
10.5.6.1.1 Brazil Endonucleases Market by Type
10.5.6.1.2 Brazil Endonucleases Market by Application
10.5.6.1.3 Brazil Endonucleases Market by End User
10.5.6.2 Argentina Endonucleases Market
10.5.6.2.1 Argentina Endonucleases Market by Type
10.5.6.2.2 Argentina Endonucleases Market by Application
10.5.6.2.3 Argentina Endonucleases Market by End User
10.5.6.3 Rest of South and Central America Endonucleases Market
10.5.6.3.1 Rest of South and Central America Endonucleases Market by Type
10.5.6.3.2 Rest of South and Central America Endonucleases Market by Application
10.5.6.3.3 Rest of South and Central America Endonucleases Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ENDONUCLEASES MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ENDONUCLEASES MARKET, KEY COMPANY PROFILES
13.1. MERCK KGAA
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. NEW ENGLAND BIOLABS, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PROMEGA CORPORATION
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GENETICS BIOTECH ASIA PVT. LTD
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. THERMO FISHER SCIENTIFIC INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. AGILENT TECHNOLOGIES, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PERKINELMER, INC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BLUEBIRD BIO, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BIOVISION, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. INTEGRATED DNA TECHNOLOGIES, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Endonucleases Market - By Type
1.3.2 Endonucleases Market - By Application
1.3.3 Endonucleases Market - By End User
1.3.4 Endonucleases Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ENDONUCLEASES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ENDONUCLEASES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ENDONUCLEASES MARKET - GLOBAL MARKET ANALYSIS
6.1. ENDONUCLEASES - GLOBAL MARKET OVERVIEW
6.2. ENDONUCLEASES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ENDONUCLEASES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. EUKARYOTIC ENZYMES
7.3.1. Overview
7.3.2. Eukaryotic Enzymes Market Forecast and Analysis
7.3.3. Neurospora Endonuclease Market
7.3.3.1. Overview
7.3.3.2. Neurospora Endonuclease Market Forecast and Analysis
7.3.4. P1 Endonuclease Market
7.3.4.1. Overview
7.3.4.2. P1 Endonuclease Market Forecast and Analysis
7.3.5. S1 Endonuclease Market
7.3.5.1. Overview
7.3.5.2. S1 Endonuclease Market Forecast and Analysis
7.3.6. Mung Bean Endonuclease I Market
7.3.6.1. Overview
7.3.6.2. Mung Bean Endonuclease I Market Forecast and Analysis
7.3.7. Dnase I Market
7.3.7.1. Overview
7.3.7.2. Dnase I Market Forecast and Analysis
7.3.8. Others Market
7.3.8.1. Overview
7.3.8.2. Others Market Forecast and Analysis
7.4. PROKARYOTIC ENZYMES
7.4.1. Overview
7.4.2. Prokaryotic Enzymes Market Forecast and Analysis
7.4.3. Bal 31 Endonuclease Market
7.4.3.1. Overview
7.4.3.2. Bal 31 Endonuclease Market Forecast and Analysis
7.4.4. T7 Endonuclease Market
7.4.4.1. Overview
7.4.4.2. T7 Endonuclease Market Forecast and Analysis
7.4.5. RecBCD Endonuclease Market
7.4.5.1. Overview
7.4.5.2. RecBCD Endonuclease Market Forecast and Analysis
7.4.6. T4 Endonuclease II Market
7.4.6.1. Overview
7.4.6.2. T4 Endonuclease II Market Forecast and Analysis
7.4.7. Others Market
7.4.7.1. Overview
7.4.7.2. Others Market Forecast and Analysis
8. ENDONUCLEASES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. POLYMERASE CHAIN REACTION (PCR)
8.3.1. Overview
8.3.2. Polymerase Chain Reaction (PCR) Market Forecast and Analysis
8.4. RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP)
8.4.1. Overview
8.4.2. Restriction Fragment Length Polymorphism (RFLP) Market Forecast and Analysis
8.5. EPIGENETICS
8.5.1. Overview
8.5.2. Epigenetics Market Forecast and Analysis
8.6. RESTRICTION DIGESTION
8.6.1. Overview
8.6.2. Restriction Digestion Market Forecast and Analysis
8.7. SEQUENCING
8.7.1. Overview
8.7.2. Sequencing Market Forecast and Analysis
8.8. CLONING
8.8.1. Overview
8.8.2. Cloning Market Forecast and Analysis
9. ENDONUCLEASES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.3.1. Overview
9.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
9.4. RESEARCH ORGANIZATIONS
9.4.1. Overview
9.4.2. Research Organizations Market Forecast and Analysis
9.5. MEDICAL INSTITUTES
9.5.1. Overview
9.5.2. Medical Institutes Market Forecast and Analysis
10. ENDONUCLEASES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Endonucleases Market Overview
10.1.2 North America Endonucleases Market Forecasts and Analysis
10.1.3 North America Endonucleases Market Forecasts and Analysis - By Type
10.1.4 North America Endonucleases Market Forecasts and Analysis - By Application
10.1.5 North America Endonucleases Market Forecasts and Analysis - By End User
10.1.6 North America Endonucleases Market Forecasts and Analysis - By Countries
10.1.6.1 United States Endonucleases Market
10.1.6.1.1 United States Endonucleases Market by Type
10.1.6.1.2 United States Endonucleases Market by Application
10.1.6.1.3 United States Endonucleases Market by End User
10.1.6.2 Canada Endonucleases Market
10.1.6.2.1 Canada Endonucleases Market by Type
10.1.6.2.2 Canada Endonucleases Market by Application
10.1.6.2.3 Canada Endonucleases Market by End User
10.1.6.3 Mexico Endonucleases Market
10.1.6.3.1 Mexico Endonucleases Market by Type
10.1.6.3.2 Mexico Endonucleases Market by Application
10.1.6.3.3 Mexico Endonucleases Market by End User
10.2. EUROPE
10.2.1 Europe Endonucleases Market Overview
10.2.2 Europe Endonucleases Market Forecasts and Analysis
10.2.3 Europe Endonucleases Market Forecasts and Analysis - By Type
10.2.4 Europe Endonucleases Market Forecasts and Analysis - By Application
10.2.5 Europe Endonucleases Market Forecasts and Analysis - By End User
10.2.6 Europe Endonucleases Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Endonucleases Market
10.2.6.1.1 Germany Endonucleases Market by Type
10.2.6.1.2 Germany Endonucleases Market by Application
10.2.6.1.3 Germany Endonucleases Market by End User
10.2.6.2 France Endonucleases Market
10.2.6.2.1 France Endonucleases Market by Type
10.2.6.2.2 France Endonucleases Market by Application
10.2.6.2.3 France Endonucleases Market by End User
10.2.6.3 Italy Endonucleases Market
10.2.6.3.1 Italy Endonucleases Market by Type
10.2.6.3.2 Italy Endonucleases Market by Application
10.2.6.3.3 Italy Endonucleases Market by End User
10.2.6.4 Spain Endonucleases Market
10.2.6.4.1 Spain Endonucleases Market by Type
10.2.6.4.2 Spain Endonucleases Market by Application
10.2.6.4.3 Spain Endonucleases Market by End User
10.2.6.5 United Kingdom Endonucleases Market
10.2.6.5.1 United Kingdom Endonucleases Market by Type
10.2.6.5.2 United Kingdom Endonucleases Market by Application
10.2.6.5.3 United Kingdom Endonucleases Market by End User
10.2.6.6 Rest of Europe Endonucleases Market
10.2.6.6.1 Rest of Europe Endonucleases Market by Type
10.2.6.6.2 Rest of Europe Endonucleases Market by Application
10.2.6.6.3 Rest of Europe Endonucleases Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Endonucleases Market Overview
10.3.2 Asia-Pacific Endonucleases Market Forecasts and Analysis
10.3.3 Asia-Pacific Endonucleases Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Endonucleases Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Endonucleases Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Endonucleases Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Endonucleases Market
10.3.6.1.1 Australia Endonucleases Market by Type
10.3.6.1.2 Australia Endonucleases Market by Application
10.3.6.1.3 Australia Endonucleases Market by End User
10.3.6.2 China Endonucleases Market
10.3.6.2.1 China Endonucleases Market by Type
10.3.6.2.2 China Endonucleases Market by Application
10.3.6.2.3 China Endonucleases Market by End User
10.3.6.3 India Endonucleases Market
10.3.6.3.1 India Endonucleases Market by Type
10.3.6.3.2 India Endonucleases Market by Application
10.3.6.3.3 India Endonucleases Market by End User
10.3.6.4 Japan Endonucleases Market
10.3.6.4.1 Japan Endonucleases Market by Type
10.3.6.4.2 Japan Endonucleases Market by Application
10.3.6.4.3 Japan Endonucleases Market by End User
10.3.6.5 South Korea Endonucleases Market
10.3.6.5.1 South Korea Endonucleases Market by Type
10.3.6.5.2 South Korea Endonucleases Market by Application
10.3.6.5.3 South Korea Endonucleases Market by End User
10.3.6.6 Rest of Asia-Pacific Endonucleases Market
10.3.6.6.1 Rest of Asia-Pacific Endonucleases Market by Type
10.3.6.6.2 Rest of Asia-Pacific Endonucleases Market by Application
10.3.6.6.3 Rest of Asia-Pacific Endonucleases Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Endonucleases Market Overview
10.4.2 Middle East and Africa Endonucleases Market Forecasts and Analysis
10.4.3 Middle East and Africa Endonucleases Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Endonucleases Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Endonucleases Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Endonucleases Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Endonucleases Market
10.4.6.1.1 South Africa Endonucleases Market by Type
10.4.6.1.2 South Africa Endonucleases Market by Application
10.4.6.1.3 South Africa Endonucleases Market by End User
10.4.6.2 Saudi Arabia Endonucleases Market
10.4.6.2.1 Saudi Arabia Endonucleases Market by Type
10.4.6.2.2 Saudi Arabia Endonucleases Market by Application
10.4.6.2.3 Saudi Arabia Endonucleases Market by End User
10.4.6.3 U.A.E Endonucleases Market
10.4.6.3.1 U.A.E Endonucleases Market by Type
10.4.6.3.2 U.A.E Endonucleases Market by Application
10.4.6.3.3 U.A.E Endonucleases Market by End User
10.4.6.4 Rest of Middle East and Africa Endonucleases Market
10.4.6.4.1 Rest of Middle East and Africa Endonucleases Market by Type
10.4.6.4.2 Rest of Middle East and Africa Endonucleases Market by Application
10.4.6.4.3 Rest of Middle East and Africa Endonucleases Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Endonucleases Market Overview
10.5.2 South and Central America Endonucleases Market Forecasts and Analysis
10.5.3 South and Central America Endonucleases Market Forecasts and Analysis - By Type
10.5.4 South and Central America Endonucleases Market Forecasts and Analysis - By Application
10.5.5 South and Central America Endonucleases Market Forecasts and Analysis - By End User
10.5.6 South and Central America Endonucleases Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Endonucleases Market
10.5.6.1.1 Brazil Endonucleases Market by Type
10.5.6.1.2 Brazil Endonucleases Market by Application
10.5.6.1.3 Brazil Endonucleases Market by End User
10.5.6.2 Argentina Endonucleases Market
10.5.6.2.1 Argentina Endonucleases Market by Type
10.5.6.2.2 Argentina Endonucleases Market by Application
10.5.6.2.3 Argentina Endonucleases Market by End User
10.5.6.3 Rest of South and Central America Endonucleases Market
10.5.6.3.1 Rest of South and Central America Endonucleases Market by Type
10.5.6.3.2 Rest of South and Central America Endonucleases Market by Application
10.5.6.3.3 Rest of South and Central America Endonucleases Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ENDONUCLEASES MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ENDONUCLEASES MARKET, KEY COMPANY PROFILES
13.1. MERCK KGAA
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. NEW ENGLAND BIOLABS, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. PROMEGA CORPORATION
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GENETICS BIOTECH ASIA PVT. LTD
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. THERMO FISHER SCIENTIFIC INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. AGILENT TECHNOLOGIES, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PERKINELMER, INC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BLUEBIRD BIO, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BIOVISION, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. INTEGRATED DNA TECHNOLOGIES, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Merck KGaA
2. New England Biolabs, Inc.
3. Promega Corporation
4. Genetics Biotech Asia Pvt. Ltd
5. Thermo Fisher Scientific Inc.
6. Agilent Technologies, Inc.
7. PerkinElmer, Inc
8. bluebird bio, Inc.
9. BioVision, Inc.
10. Integrated DNA Technologies, Inc.
11. Prospec-Tany Technogene Ltd.
12. abm, Inc.
13. Epicenter Technologies Corporation
14. Affymetrix, Inc.
15. Illumina, Inc.
1. Merck KGaA
2. New England Biolabs, Inc.
3. Promega Corporation
4. Genetics Biotech Asia Pvt. Ltd
5. Thermo Fisher Scientific Inc.
6. Agilent Technologies, Inc.
7. PerkinElmer, Inc
8. bluebird bio, Inc.
9. BioVision, Inc.
10. Integrated DNA Technologies, Inc.
11. Prospec-Tany Technogene Ltd.
12. abm, Inc.
13. Epicenter Technologies Corporation
14. Affymetrix, Inc.
15. Illumina, Inc.
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.